Еверолимус Крка

Everolimus Krka is an oral immunosuppressant and mTOR inhibitor used to prevent organ transplant rejection and treat certain cancers. This EU-manufactured generic provides a widely prescribed option for patients requiring long-term immune management.

Everolimus is prescribed to reduce the risk of organ transplant rejection in kidney and heart transplant patients when combined with other immunosuppressants. It is also used to treat advanced kidney cancer, certain types of pancreatic neuroendocrine tumors, and tuberous sclerosis complex-related conditions.

Everolimus helps regulate the immune system by inhibiting specific pathways that trigger organ rejection after transplant. Patients may experience improved graft stability and reduced tumor progression when taken as directed. Individual responses can vary based on medical history and concurrent therapies.

Store everolimus at room temperature away from moisture and light. Keep the medication in its original packaging until ready to use. Always handle with care and follow local disposal guidelines for unused or expired tablets to prevent accidental ingestion.

Everolimus may interact with other drugs that affect liver enzymes, such as certain antifungals or antibiotics. Grapefruit and grapefruit juice can also interfere with how the body processes everolimus. Discuss all current medications with a healthcare provider before starting this treatment.